BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 16230262)

  • 1. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
    J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin-C and mortality in elderly persons with heart failure.
    Shlipak MG; Katz R; Fried LF; Jenny NS; Stehman-Breen C; Newman AB; Siscovick D; Psaty BM; Sarnak MJ
    J Am Coll Cardiol; 2005 Jan; 45(2):268-71. PubMed ID: 15653026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of cystatin C and prognosis following admission for acute heart failure.
    Campbell CY; Clarke W; Park H; Haq N; Barone BB; Brotman DJ
    Am J Cardiol; 2009 Aug; 104(3):389-92. PubMed ID: 19616673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction.
    Carrasco-Sánchez FJ; Galisteo-Almeda L; Páez-Rubio I; Martínez-Marcos FJ; Camacho-Vázquez C; Ruiz-Frutos C; Pujol-De La Llave E
    J Card Fail; 2011 Jan; 17(1):31-8. PubMed ID: 21187262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.
    Villa P; Jiménez M; Soriano MC; Manzanares J; Casasnovas P
    Crit Care; 2005 Apr; 9(2):R139-43. PubMed ID: 15774046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.
    Jernberg T; Lindahl B; James S; Larsson A; Hansson LO; Wallentin L
    Circulation; 2004 Oct; 110(16):2342-8. PubMed ID: 15477399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
    Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
    Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
    Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
    Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure.
    Aronson D; Mittleman MA; Burger AJ
    Am J Med; 2004 Apr; 116(7):466-73. PubMed ID: 15047036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C and the risk of death and cardiovascular events among elderly persons.
    Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
    N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes.
    Macisaac RJ; Tsalamandris C; Thomas MC; Premaratne E; Panagiotopoulos S; Smith TJ; Poon A; Jenkins MA; Ratnaike SI; Power DA; Jerums G
    Diabet Med; 2007 Apr; 24(4):443-8. PubMed ID: 17388960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer].
    Bodnar L; Wcisło GB; elichowski G; Raczka A; Wańkowicz Z; Szczylik C
    Pol Merkur Lekarski; 2008 Apr; 24(142):307-11. PubMed ID: 18634361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.
    Kawai K; Kawashima S; Miyazaki T; Tajiri E; Mori M; Kitazaki K; Shirotani T; Inatome T; Yamabe H; Hirata K; Yokoyama M
    J Cardiol; 2010 Jan; 55(1):99-107. PubMed ID: 20122555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.